OIMU
BSX icon

Osmosis Investment Management UK’s Boston Scientific BSX Stock Holding History

Osmosis Investment Management UK’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93M Sell
68,551
-80,125
-54% -$4.35M 0.14% 146
2026
Q1 		$9.33M Buy
148,676
+53,203
+56% +$4.26M 0.25% 94
2025
Q4 		$9.1M Buy
+95,473
New +$9.36M 0.23% 100

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Osmosis Investment Management UK's BSX Position: Q2 2026 in Review

Osmosis Investment Management UK reduced its Boston Scientific (BSX) stake by 54% in Q2 2026, selling an estimated $4.35M and leaving 68,551 shares worth $2.93M. The position accounts for 0.14% of the portfolio, ranked #146.

Osmosis Investment Management UK first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.33M in Q1 2026. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Osmosis Investment Management UK held 68,551 shares of Boston Scientific worth $2.93M as of Q2 2026.
  • Osmosis Investment Management UK sold 80,125 Boston Scientific shares in Q2 2026, an estimated $4.35M.
  • Boston Scientific made up 0.14% of Osmosis Investment Management UK's portfolio in Q2 2026, its #146 holding.
  • Osmosis Investment Management UK first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Osmosis Investment Management UK's Boston Scientific position peaked at $9.33M in Q1 2026.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.